½ÃÀ庸°í¼­
»óǰÄÚµå
1474882

ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : ÄÄÆ÷³ÍÆ®º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)

Digital Health For Obesity Market Size, Share & Trends Analysis Report By Component (Hardware, Software, Services), By End-use (Patients, Providers, Payers), By Region, And Segment Forecasts, 2024 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 130 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽЏ®Æ÷Æ®¿¡ µû¸£¸é ºñ¸¸¿ë ¼¼°èÀÇ µðÁöÅÐ Çコ ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 1,968¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2024-2030³âÀÇ CAGRÀº 22.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

19¾ï ¸í ÀÌ»óÀÇ ¼ºÀÎÀÌ ºñ¸¸ÀÎ ¼¼°è ºñ¸¸À² Áõ°¡·Î ÀÎÇØ üÁß °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ½ÃÀå ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¾É¾Æ¼­ »ýȰÇÏ´Â ½À°ü°ú °Ç°­¿¡ ÁÁÁö ¾ÊÀº ½Ä½À°ü µî ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ º¯È­°¡ ÀÌ·¯ÇÑ ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ´ç´¢º´, ½ÉÇ÷°ü Áúȯ µî ºñ¸¸°ú °ü·ÃµÈ °Ç°­ À§Çè¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó È¿°úÀûÀÎ ÁßÀçÃ¥À» ã´Â »ç¶÷µéÀÌ ´Ã¾î³ª°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±â¼ú ¹ßÀü°ú µðÁöÅÐ °Ç°­ ¼Ö·ç¼Ç, °³ÀÎ ¸ÂÃãÇü ½Ä´Ü °ü¸® ¾Û, ¿þ¾î·¯ºí ±â±âÀÇ µîÀåÀ¸·Î üÁß °ü¸®¸¦ À§ÇØ ±â¼úÀ» »ç¿ëÇÏ´Â »ç¶÷µéÀÌ ´Ã¾î³ª¸é¼­ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °Ç°­ ÀνÄ, ±â¼ú Çõ½Å, È¿°úÀûÀΠüÁß °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ½Ã±ÞÇÑ ¿ä±¸°¡ ±³Â÷Çϸ鼭 ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ ºñ¸¸¿ë µðÁöÅÐ Çコ ¼Ö·ç¼Ç ½ÃÀåÀÇ ¼ºÀåÀº °Ç°­ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ºñ¸¸ ¹× °ü·Ã °Ç°­ »óÅÂÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ºñ¸¸¿ë µðÁöÅÐ Çコ ¼Ö·ç¼Ç ½ÃÀåÀÇ ¼ºÀå¿¡ ±âÀÎÇÕ´Ï´Ù. ÀΰøÁö´É(AI), ¸Ó½Å·¯´×(ML) µî ÷´Ü ±â¼úÀÇ µµÀÔÀº ½ÃÀå È®´ë¿¡ ´õ¿í ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â iOS, ¾Èµå·ÎÀÌµå µî ´Ù¾çÇÑ OS¿¡¼­ ¿ëµµÀ» Á¦°øÇÏ´Â ´Ù¾çÇÑ Ã¼Áß °¨·® ¾ÛÀÌ µîÀåÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¾ÛÀº ¶óÀÌÇÁ½ºÅ¸ÀÏ ¸ð´ÏÅ͸µ, ½Ä´Ü ÃßÀû, üÁß °ü¸®, ¿îµ¿ ¸ð´ÏÅ͸µ µî ´Ù¾çÇÑ Ãø¸éÀ» Áö¿øÇÕ´Ï´Ù. Àü ¼¼°è ºñ¸¸À²Àº Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖÀ¸¸ç, üÁß °¨·® ¾Û¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå¿¡¼­´Â COVID-19 ÆÒµ¥¹ÍÀÇ ¿µÇâÀ¸·Î ¿ø°Ý ȯÀÚ °ü¸®(RPM)¿¡ ´ëÇÑ ¼ö¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Æí¸®ÇÏ°í »ç¿ëÇϱ⠽¬¿î ÅøÀÇ µµÀÔÀ¸·Î Ä¡·áÀÇ Àå¾Ö¹°ÀÌ ÁÙ¾îµé°í ÀæÀº ´ë¸é Áø·áÀÇ Çʿ伺ÀÌ »ç¶óÁ³À¸¸ç, RPMÀ» ÅëÇØ ÀÇ·á Àü¹®°¡°¡ ȯÀÚ¸¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇϰí Àû½Ã¿¡ ¿ø°Ý Áö¿øÀ» Á¦°øÇÒ ¼öÀÖ¾î À̵¿ÀÌ ¾î·Æ°Å³ª ¹Ù»Û ÀÏÁ¤À» °¡Áø »ç¶÷µé¿¡°Ô À¯¸®ÇÕ´Ï´Ù. ÀÔÁõµÇ¾ú½À´Ï´Ù. ÀÌ ºñ¿ë È¿À²ÀûÀÌ°í Æí¸®ÇÑ Á¢±Ù ¹æ½ÄÀº È¿°úÀûÀΠüÁß °ü¸®¸¦ °¡´ÉÇÏ°Ô ÇÏ°í ´õ ³ôÀº Âü¿©¿Í °³ÀÎÈ­µÈ ÀǷḦ ÃËÁøÇÕ´Ï´Ù.

ÀÌ ½ÃÀå¿¡¼­ »ç¾÷À» ¿î¿µÇÏ´Â ÁÖ¿ä ±â¾÷Àº Á¦Ç° Çü¼º°ú µµ´Þ ¹üÀ§ È®´ë¿¡ ÁßÁ¡À» µÎ°í Á¦ÈÞ, ÀμöÇÕº´(M&A), ÆÄÆ®³Ê½Ê, Á¦Ç° Ãâ½Ã µîÀÇ Àü·«À» äÅÃÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2023³â 10¿ù, ÀÇ·á Á¤º¸ Á¤¸®¸¦ À§ÇÑ ÀΰøÁö´É Ȱ¿ë Àü¹® ½ºÅ¸Æ®¾÷ÀÎ Mendel.ai´Â AI ±â¹Ý Ç÷§ÆûÀÎ Hypercube¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Çõ½ÅÀûÀÎ ½Ã½ºÅÛÀº ±¸Á¶È­µÈ ÅØ½ºÆ® µ¥ÀÌÅÍ¿Í ºñÁ¤Çü ÅØ½ºÆ® µ¥ÀÌÅ͸¦ ÅëÇÕÇÏ¿© ºÐ¼®À» ¹ÎÁÖÈ­Çϰí, »ç¿ëÀÚ°¡ ÀÚÀ¯ ÅØ½ºÆ®·Î Áú¹®À» ´øÁú ¼ö ÀÖÀ¸¸ç, Hypercube´Â ƯÁ¤ ȯÀÚ µ¥ÀÌÅÍ¿¡¼­ µµÃâµÈ °á°ú¸¦ Á¦°øÇÏ¿© ÀÇ·á Á¤º¸ ºÐ¼®ÀÇ Á¢±Ù¼º°ú È¿À²¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. 2023³â 5¿ù, Noom, Inc.´Â Áúº´À¸·Î¼­ÀÇ ºñ¸¸°ú ½Î¿ì±â À§ÇØ ¼³°èµÈ Noom Med¸¦ ¹ßÇ¥ÇßÀ¸¸ç, Noom Med´Â ´Ù¾çÇÑ ¿ø°ÝÀÇ·á ¼­ºñ½º¿Í NoomÀÇ °³ÀÎÈ­µÈ ½É¸®ÇÐÀû ÅøÀ» ÅëÇÕÇÏ¿© Áö¼ÓÀûÀΠüÁß °¨·®À» ÃËÁøÇÕ´Ï´Ù. ÀÌ ÇÁ·Î±×·¥Àº ´®ÀÇ ¼ÒºñÀÚ ¼Ö·ç¼ÇÀ¸·Î ³Î¸® »ç¿ëµÇ´Â ´® ¿þÀÌÆ®(Noom Weight)¸¦ È®ÀåÇÑ °ÍÀ¸·Î, ½É¸®ÇÐÀû ¿ø¸®, Àΰ£ Áö¿ø ¹× ±â¼úÀ» Ȱ¿ëÇÏ¿© ȯÀÚ°¡ Áö¼ÓÀûÀΠüÁß °¨·®¿¡ ´ëÇÑ Àå¾Ö¹°À» ±Øº¹ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

ºñ¸¸À» À§ÇÑ µðÁöÅÐ Çコ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • ÄÄÆ÷³ÍÆ®º°·Î´Â ¼­ºñ½º ºÎ¹®ÀÌ 2023³â °¡Àå Å« ½ÃÀå ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀº ¼³Ä¡, À¯Áöº¸¼ö, ±³À° ¹× ±âŸ ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù.
  • ÃÖÁ¾ ¿ëµµº°·Î´Â ȯÀÚ ºÐ¾ß°¡ 2023³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ Áß CAGRÀÌ 20%¸¦ »óȸÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ºÏ¹Ì´Â ÀÇ·á IT ÁöÃâ Áõ°¡, ÀûÀýÇÑ µðÁöÅÐ ÀÎÇÁ¶óÀÇ °¡¿ë¼º, ±â¼ú ¹ßÀü ¹× ½Å»ý ±â¾÷ÀÇ ÃâÇöÀ¸·Î ÀÎÇØ 2023³â ¸ÅÃâ Á¡À¯À²ÀÌ 35%¸¦ ³Ñ¾î¼­¸ç ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • ¸ð½ÃÀå Àü¸Á
    • °ü·Ã/º¸Á¶ÀûÀÎ ½ÃÀå Àü¸Á.
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ºñ¸¸¿ë µðÁöÅп¡ ¸£½º ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® - PorterÀÇ »ê¾÷ ºÐ¼®
    • PESTEL ºÐ¼®
  • ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå¿¡¼­ COVID-19ÀÇ ¿µÇâ

Á¦4Àå ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå : ÄÄÆ÷³ÍÆ® ÃßÁ¤¡¤µ¿Ç⠺м®

  • Á¤ÀÇ¿Í ¹üÀ§
  • ÄÄÆ÷³ÍÆ®ÀÇ ½ÃÀå Á¡À¯À², 2023³â¡¤2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå : ÄÄÆ÷³ÍÆ®º° Àü¸Á
  • ¼ÒÇÁÆ®¿þ¾î
  • Çϵå¿þ¾î
  • ¼­ºñ½º

Á¦5Àå ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

  • Á¤ÀÇ¿Í ¹üÀ§
  • ÃÖÁ¾ ¿ëµµÀÇ ½ÃÀå Á¡À¯À², 2023³â¡¤2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå, ÃÖÁ¾ ¿ëµµº° Àü¸Á
  • ȯÀÚ
  • Á¦°øÀÚ
  • ÁöºÒÀÚ
  • ±âŸ

Á¦6Àå ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ªÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â¡¤2030³â
  • Áö¿ªÀÇ ½ÃÀå ´ë½Ãº¸µå
  • ¼¼°èÀÇ Áö¿ªÀÇ ½ÃÀå ½º³À¼ô
  • SWOT ºÐ¼®, Áö¿ªº°
  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦7Àå °æÀï ±¸µµ

  • ÁÖ¿ä ½ÃÀå Âü¿© ±â¾÷¿¡ ÀÇÇÑ ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®
  • ±â¾÷/°æÀï ºÐ·ù
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå ÇöȲ ºÐ¼®, 2023³â
  • ±â¾÷ ¸®½ºÆ®
    • WW International
    • MyFitnessPal Inc.
    • Teladoc
    • FitnessKeeper
    • My Diet Coach
    • PlateJoy
    • Tempus
    • Fitbit, Inc.
    • Noom
    • WellDoc
    • Sidekick Health
    • BioAge Labs
KSA 24.05.20

Digital Health For Obesity Market Growth & Trends:

The global digital health for obesity market size is anticipated to reach USD 196.8 billion by 2030 and is projected to grow at a CAGR of 22.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising global obesity rates, with over 1.9 billion adults affected, have created a substantial market demand for weight management solutions. Lifestyle changes, including sedentary habits and unhealthy dietary choices, contribute significantly to this growth. The increasing awareness of obesity-related health risks, such as diabetes and cardiovascular diseases, propels individuals toward seeking effective interventions. In addition, advancements in technology and the emergence of digital health solutions, personalized dietary guidance apps, and wearable devices, further drive market growth as people increasingly turn to technology for managing their weight. The intersection of health consciousness, technological innovation, and the urgent need for effective weight management solutions collectively fuels the market growth.

Furthermore, the growth of digital health solutions in obesity market can be attributed to a rising prevalence of obesity and associated health conditions, alongside growing health awareness. Incorporating advanced technologies such as artificial intelligence (AI) and machine learning (ML) is anticipated to further contribute to market expansion. Various weight loss apps are being launched in that market that offer applications on various operating systems, including iOS, Android, and others. These apps cater to various aspects such as lifestyle monitoring, diet tracking, weight management, exercise monitoring, and more. As obesity rates continue to rise globally, there is an increasing demand for weight loss apps, and companies are leveraging this trend to their advantage.

Furthermore, the digital health obesity market has witnessed increased acceptance of remote patient management (RPM) due to the impact of the COVID-19 pandemic. Implementing convenient and accessible tools has diminished obstacles to care, eliminating the necessity for frequent in-person visits. RPM allows healthcare professionals to consistently monitor patients and provide timely remote assistance, proving advantageous for individuals with limited mobility or hectic schedules. This cost-effective and convenient approach enables effective weight management and promotes heightened engagement and personalized healthcare.

The major players operating in the market are adopting strategies such as collaborations, mergers and acquisitions, and partnerships, product launches, with a major focus on enhancing product formation and reach. For instance, in October 2023, Mendel.ai, a startup specializing in the utilization of artificial intelligence for organizing medical information, unveiled Hypercube, an AI-powered platform. This innovative system integrates both structured and unstructured text data, democratizing analytics and enabling users to pose questions in free text. Hypercube then provides outcomes derived from specific patient data, enhancing accessibility and efficiency in medical information analysis. In May 2023, Noom, Inc. introduced Noom Med, designed to combat obesity as a disease. Noom Med integrates a range of telehealth services with Noom's personalized psychological tools to facilitate enduring weight loss. This program, an augmentation of Noom Weight, the company's widely used consumer-facing solution, utilizes psychological principles, human assistance, and technology to empower patients in overcoming obstacles to sustained weight loss.

Digital Health For Obesity Market Report Highlights:

  • Based on component, the services segment accounted for the largest market revenue share in 2023. This growth can be attributed to the growing demand for installation, maintenance, training, and other services
  • Based on end-use, the patient segment accounted with the largest market share in 2023 and is anticipated to witness at the fastest CAGR of over 20% over the forecast period
  • North America dominated the market in 2023 with a revenue share of over 35%, owing to growing healthcare IT expenditure, availability of adequate digital infrastructure, technological advancements, the emergence of startups

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Component
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Component outlook
    • 2.2.2. End Use outlook.
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Digital Health for Obesity Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing adoption of digital technology in obesity care
      • 3.2.1.2. Increasing use of artificial intelligence (AI), internet of things (IoT), and big data
      • 3.2.1.3. Growing adoption of mobile health applications and technologies
      • 3.2.1.4. Increasing burden of mental disorders
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Privacy and security concerns
      • 3.2.2.2. Lack of healthcare infrastructure
  • 3.3. Digital Health for Obesity Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Digital Health for Obesity Market COVID-19 Impact

Chapter 4. Digital Health for Obesity Market: Component Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Component Market Share, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Digital Health for Obesity Market by Component Outlook
  • 4.5. Software
    • 4.5.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 4.6. Hardware
    • 4.6.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 4.7. Services
    • 4.7.1. Market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 5. Digital Health for Obesity Market: End-use Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. End Use Market Share, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Digital Health for Obesity Market, by End-use Outlook
  • 5.5. Patients
    • 5.5.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 5.6. Providers
    • 5.6.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 5.7. Payers
    • 5.7.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 6. Digital Health for Obesity Market: Regional Estimates & Trend Analysis, By Component, By End-use

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. SWOT Analysis, by Region
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.7.6. Singapore
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Singapore market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Key company market position analysis, 2023
  • 7.4. List of Companies
    • 7.4.1. WW International
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. MyFitnessPal Inc.
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Teladoc
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. FitnessKeeper
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. My Diet Coach
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. PlateJoy
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Tempus
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Fitbit, Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Noom
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. WellDoc
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Sidekick Health
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. BioAge Labs
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦